This finding was confirmed in a longitudinal study, where CSF MCP-1 levels were significantly elevated in prodromal Alzheimer’s disease patients when compared to controls and associated with faster cognitive decline and development of dementia within a shorter time period [157] (Table 2). The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.